Health Products

Venlafaxine XR Product Recall (2019-12-20)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II

Summary

Product

Venlafaxine XR 37.5 mg Capsule

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDIN, NPN, DIN-HIMDosage formStrength
W07930B. Teva-Venlafaxine XR 150 mg Capsule
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
DIN 02275058Capsule (Extended Release)Venlafaxine hydrochloride 150 mg
W05930Venlafaxine XR 37.5 mg Capsule
Recalling Firm
Sanis Health
243 Consumers Road
Toronto
M2J 4W8
Ontario
CANADA
Marketing Authorization Holder
Sanis Health
243 Consumers Road
Toronto
M2J 4W8
Ontario
CANADA
DIN 02354713Capsule (Extended Release)Venlafaxine hydrochloride 37.5 mg

Introduction

  1. Venlafaxine XR 37.5 mg Capsule
  2. Teva-Venlafaxine XR 150 mg Capsule

Reason

The dissolution is out of trend in the affected lot.

Depth of distribution

Healthcare Establishments, Retailers
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime